Particle.news
Download on the App Store
3 ARTICLES
·
2mo ago

Rare Candida Auris Brain Infection Underscores Global Hospital Threat

Surveillance figures topping 4,500 U.S. cases in 2023 with mandatory reporting in England since April highlight the difficulty of containing this multidrug-resistant pathogen.

Eine digitale Darstellung des Hefepilzes Candida auris. Eine Infektion am Menschen wurde erstmals 2009 registriert.
Candida auris ist ein tödlicher, multiresistenter Pilz, der weltweit Krankenhäuser bedroht.
Image

Overview

  • WHO has placed Candida auris among its highest-priority fungal threats as infections surge in hospitals worldwide.
  • CDC data show 4,514 U.S. cases in 2023 and Germany’s National Reference Centre reported 77 infections last year, marking a significant increase.
  • England designated Candida auris a notifiable condition in April 2025 following 134 cases recorded between November 2024 and April.
  • A newly published case report describes a 34-year-old patient in the UAE who developed a hospital-acquired brain infection that required seven months of antifungal therapy.
  • Clinicians warn that delayed diagnosis, routine test misidentification and the fungus’s persistence on surfaces amplify outbreak risks among vulnerable patients.